col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


69 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Harm Reduction Journal
  original article Date Title Authors   All Authors
1 [GO] 2025―Feb―01 Assessment of knowledge and behaviors of an opioid overdose education and naloxone distribution program during the coronavirus disease 2019 pandemic Alexis E. Horace, Ojochogwu Atawodi-Alhassan
2 [GO] 2025―Jan―07 The impact of Covid-19 on harm reduction policies in Iran: an interrupted time series analysis Siavash Beiranvand, Meysam Behzadifar, Aidin Aryankhesal, Seyed Jafar Ehsanzadeh, Masoud Behzadifar
3 [GO] 2024―Oct―16 COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC C. Lacoux, V. Villes, L. Riegel, S. Coulmain, N. Lorente, S. Eddine Derras, et al. (+4)
4 [GO] 2024―Aug―23 Increases in housing rules and surveillance during COVID-19: impacts on overdose and overdose response in a community-based cohort of sex workers who use drugs in Vancouver, BC Jenn McDermid, Jennie Pearson, Melissa Braschel, Sarah Moreheart, Rory Marck, Kate Shannon, et al. (+2)
5 [GO] 2024―Jul―31 Correction: The managers’ perspectives on service providing in women’s harm reduction centers during the COVID-19 pandemic: mixed method study Azam Rahmani, Maryam Janatolmakan, Elham Rezaei, Malihe Tabarrai
6 [GO] 2024―Jul―24 Challenges of the COVID-19 pandemic on women’s HIV harm reduction centers: a mixed-methods study Azam Rahmani, Maryam Janatolmakan, Elham Rezaei, Leila Allahqoli, Arezoo Fallahi, Elham Ebrahimi, et al. (+3)
7 [GO] 2024―Jul―12 The managers' perspectives on service providing in women's harm reduction centers during the COVID-19 pandemic: mixed method study Azam Rahmani, Maryam Janatolmakan, Elham Rezaei, Malihe Tabaraei
8 [GO] 2024―Jun―19 Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies Linda Elise Couëssurel Wüsthoff, Fridtjof Lund-Johansen, Kathleen Henriksen, Gull Wildendahl, Jon-Aksel Jacobsen, Leni Gomes, et al. (+5)
9 [GO] 2024―Jun―07 “If it wasn’t for them, I don’t think I would be here”: experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis Gillian Kolla, Bernie Pauly, Fred Cameron, Heather Hobbs, Corey Ranger, Jane McCall, et al. (+5)
10 [GO] 2024―May―16 The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis Sanjana Mitra, Zachary Bouck, Sarah Larney, Camille Zolopa, Stine Høj, Nanor Minoyan, et al. (+8)
11 [GO] 2024―May―08 Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland Eshan U. Patel, Suzanne M. Grieb, Abigail K. Winiker, Jennifer Ching, Catherine G. Schluth, Shruti H. Mehta, et al. (+2)
12 [GO] 2024―Apr―27 Receipt of COVID-19 emergency funds and engagement in sex work during COVID-19 among people who use drugs: evidence from Vancouver, Canada Erica McAdam, Kanna Hayashi, Zishan Cui, Haleigh Anderson, Scarlett Nelson, M.-J. Milloy, Kora DeBeck
13 [GO] 2024―Apr―25 “It didn’t hurt me”: patients’ and providers’ perspectives on unsupervised take-home doses, drug diversion, and overdose risks in the provision of medication for opioid use disorder during COVID-19 in San Juan, Puerto Rico Roberto Abadie, Celia B. Fisher
14 [GO] 2024―Apr―16 Associations of U.S. state-level COVID-19 policies intensity with cannabis sharing behaviors in 2020 Ryan D. Assaf, Rita Hamad, Marjan Javanbakht, Onyebuchi A. Arah, Steven J. Shoptaw, Ziva D. Cooper, Pamina M. Gorbach
15 [GO] 2024―Jan―20 Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site Gillian Kolla, Chowdhury Nishwara Tarannum, Kaitlin Fajber, Fiqir Worku, Kris Norris, Cathy Long, et al. (+9)
16 [GO] 2023―Sep―02 Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency Tyler S. Bartholomew, Hansel E. Tookes, Teresa A. Chueng, Ricky N. Bluthenthal, Lynn D. Wenger, Alex H. Kral, Barrot H. Lambdin
17 [GO] 2023―Jul―31 Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study Jenna van Draanen, Jonah Hamilton, Jeffrey Morgan, Scott Maxwell, Tara Taylor, Lindsey Richardson, Seonaid Nolan
18 [GO] 2023―Jul―29 Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study Farihah Ali, Ashima Kaura, Cayley Russell, Matthew Bonn, Julie Bruneau, Nabarun Dasgupta, et al. (+5)
19 [GO] 2023―Jun―14 Community outbreak of COVID-19 among people who use drugs attending a harm reduction centre in Barcelona, Spain Nacho Sánchez-Valdivia, Maria Gabriela Barbaglia, Marc Olivella-Cirici, Noelia Girona Marcos, Mercè Gotsens, Amaia Garrido Albaina, et al. (+3)
20 [GO] 2023―Jun―09 Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study Lyra Cooper, Joseph G. Rosen, Leanne Zhang, Danielle Pelaez, Praise F. Olatunde, Jill Owczarzak, et al. (+2)
21 [GO] 2023―May―03 COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City Don C. Des Jarlais, Chenziheng Allen Weng, Jonathan Feelemyer, Courtney McKnight
22 [GO] 2023―Mar―26 “The new normal has become a nonstop crisis”: a qualitative study of burnout among Philadelphia’s harm reduction and substance use disorder treatment workers during the COVID-19 pandemic Ijeoma C. Unachukwu, Matthew P. Abrams, Abby Dolan, Kehinde Oyekemi, Zachary F. Meisel, Eugenia C. South, Shoshana V. Aronowitz
23 [GO] 2023―Mar―24 Opioid overdose prevention education in Texas during the COVID-19 pandemic Charles W. Mathias, Diana M. Cavazos, Kelly McGlothen-Bell, Allison D. Crawford, Brieanna Flowers-Joseph, Zhan Wang, Lisa M. Cleveland
24 [GO] 2023―Mar―09 Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey Sarah Brothers, Adam Palayew, Caty Simon, Abby Coulter, Knina Strichartz, Nick Voyles, Louise Vincent
25 [GO] 2023―Feb―25 Puff, Puff, Don’t Pass: harm reduction for cannabis use during a viral respiratory pandemic Ryan D. Assaf, Marjan Javanbakht, Pamina M. Gorbach, Onyebuchi A. Arah, Steven J. Shoptaw, Ziva D. Cooper
26 [GO] 2023―Feb―23 SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya Shradha Doshi, Hanley Kingston, Ashley S. Tseng, Bhavna H. Chohan, Betsy Sambai, Brandon L. Guthrie, et al. (+9)
27 [GO] 2023―Feb―21 Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic Sean T. Allen, Kristin E. Schneider, Miles Morris, Saba Rouhani, Samantha J. Harris, Brendan Saloner, Susan G. Sherman
28 [GO] 2023―Feb―04 Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation Lisa Frueh, Alexandra B. Collins, Roxxanne Newman, Nancy P. Barnett, Josiah D. Rich, Melissa A. Clark, et al. (+2)
29 [GO] 2023―Feb―02 The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study Mercy Ude, Czarina N. Behrends, Shea Kelly, Bruce R. Schackman, Allan Clear, Rebecca Goldberg, et al. (+2)
30 [GO] 2023―Jan―07 Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA Magally Torres-Leguizamon, Jamie Favaro, Dan Coello, Emmanuel G. Reynaud, Thomas Néfau, Catherine Duplessy
31 [GO] 2022―Dec―12 Female sex workers and police violence during the Covid-19 health crisis in 2020-2021: results from the EPIC multi-country community-based research program in Argentina I. Aristegui, J. Castro Avila, V. Villes, R. M. Delabre, G. Orellano, M. Aguilera, et al. (+6)
32 [GO] 2022―Dec―12 Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study Katy Holloway, Shannon Murray, Marian Buhociu, Alisha Arthur, Rondine Molinaro, Sian Chicken, et al. (+7)
33 [GO] 2022―Nov―19 Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois Alex Rains, Mary York, Rebecca Bolinski, Jerel Ezell, Lawrence J. Ouellet, Wiley D. Jenkins, Mai T. Pho
34 [GO] 2022―Nov―18 Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada Rachel Cassie, Kanna Hayashi, Kora DeBeck, M.-J. Milloy, Zishan Cui, Carol Strike, et al. (+2)
35 [GO] 2022―Oct―26 The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals Mar Bosch-Arís, Laia Gasulla, Teresa de Gispert, Lidia Segura, Joan Colom
36 [GO] 2022―Sep―07 Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia Daniel O’Keefe, Michael Livingston, Reece D. Cossar, Phoebe Kerr, David Jacka, Paul Dietze
37 [GO] 2022―Jul―27 Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic Kimberly Chieh, Ishika Patel, Lauren Walter, Li Li
38 [GO] 2022―Jul―22 The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state Kinna Thakarar, Michael Kohut, Rebecca Hutchinson, Rebecca Bell, Hannah E. Loeb, Debra Burris, Kathleen M. Fairfield
39 [GO] 2022―Jul―15 “We were building the plane as we were flying it, and we somehow made it to the other end”: syringe service program staff experiences and well-being during the COVID-19 pandemic Andrea Wang, Raagini Jawa, Sarah Mackin, Liz Whynott, Connor Buchholz, Ellen Childs, Angela R. Bazzi
40 [GO] 2022―Jul―14 The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19 Karen McCrae, Stephanie Glegg, Marie-Éve Goyer, Bernard Le Foll, Rupi Brar, Christy Sutherland, Nadia Fairbairn
41 [GO] 2022―Jul―02 Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs Fiona N. Conway, Jake Samora, Katlyn Brinkley, Haelim Jeong, Nina Clinton, Kasey R. Claborn
42 [GO] 2022―Jun―29 Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic David Dadiomov, Maria Bolshakova, Melania Mikhaeilyan, Rebecca Trotzky-Sirr
43 [GO] 2022―Jun―03 Uptake of COVID-19 vaccination among people who inject drugs Jenny Iversen, Handan Wand, Robert Kemp, Jude Bevan, Myf Briggs, Kate Patten, et al. (+2)
44 [GO] 2022―May―25 Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada Mana Moshkforoush, Kora DeBeck, Rupinder Brar, Nadia Fairbairn, Zishan Cui, M.-J. Milloy, et al. (+8)
45 [GO] 2022―May―19 Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky Jennifer L. Glick, Suzanne M. Grieb, Samantha J. Harris, Brian W. Weir, Katherine C. Smith, Tyler Puryear, et al. (+2)
46 [GO] 2022―Apr―18 Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada Nanor Minoyan, Stine Bordier Høj, Camille Zolopa, Dragos Vlad, Julie Bruneau, Sarah Larney
47 [GO] 2022―Mar―21 The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study Brendan Lew, Claire Bodkin, Robin Lennox, Timothy O’Shea, Gillian Wiwcharuk, Suzanne Turner
48 [GO] 2022―Mar―15 Changes in cannabis use and associated correlates during France’s first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey Salim Mezaache, Cécile Donadille, Victor Martin, Maëla Le Brun Gadelius, Laurent Appel, Bruno Spire, et al. (+3)
49 [GO] 2022―Mar―09 The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study David Otiashvili, Tamar Mgebrishvili, Ada Beselia, Irina Vardanashvili, Kostyantyn Dumchev, Tetiana Kiriazova, Irma Kirtadze
50 [GO] 2022―Feb―04 The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19 Jennifer J. Carroll, Sarah Mackin, Clare Schmidt, Michelle McKenzie, Traci C. Green
51 [GO] 2022―Jan―29 How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation Trang Thu Nguyen, Giang Thi Hoang, Duc Quang Nguyen, Anh Huu Nguyen, Ngoc Anh Luong, Didier Laureillard, et al. (+10)
52 [GO] 2021―Dec―06 Managed alcohol: one community’s innovative response to risk management during COVID-19 Heidi Brocious, Kathi Trawver, LaVerne Xilegg Demientieff
53 [GO] 2021―Dec―04 Investigating the impact of COVID-19 on performance and image enhancing drug use Matthew Dunn, Timothy Piatkowski
54 [GO] 2021―Nov―24 The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services Yesenia Aponte-Melendez, Pedro Mateu-Gelabert, Chunki Fong, Benjamin Eckhardt, Shashi Kapadia, Kristen Marks
55 [GO] 2021―Aug―31 How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey Sharon Cox, Emma Ward, Louise Ross, Caitlin Notley
56 [GO] 2021―Aug―16 Opioid overdose crises during the COVID-19 pandemic: implication of health disparities Ishika Patel, Lauren A. Walter, Li Li
57 [GO] 2021―Aug―05 A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone Melissa Perri, Natalie Kaminski, Matthew Bonn, Gillian Kolla, Adrian Guta, Ahmed M. Bayoumi, et al. (+5)
58 [GO] 2021―Jun―12 “You know, we can change the services to suit the circumstances of what is happening in the world”: a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland Tessa Parkes, Hannah Carver, Wendy Masterton, Danilo Falzon, Joshua Dumbrell, Susan Grant, Iain Wilson
59 [GO] 2021―May―10 Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic K. Lindqvist, C. Wallmofeldt, E. Holmén, A. Hammarberg, M. Kåberg
60 [GO] 2021―Mar―03 ‘They already operated like it was a crisis, because it always has been a crisis’: a qualitative exploration of the response of one homeless service in Scotland to the COVID-19 pandemic Tessa Parkes, Hannah Carver, Wendy Masterton, Danilo Falzon, Josh Dumbrell, Susan Grant, Iain Wilson
61 [GO] 2021―Feb―20 The drug war must end: The right to life, liberty and security of the person during the COVID-19 pandemic for people who use drugs Russ Maynard, Ehsan Jozaghi
62 [GO] 2021―Feb―20 Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia Amanda Roxburgh, Marianne Jauncey, Carolyn Day, Mark Bartlett, Shelley Cogger, Paul Dietze, et al. (+3)
63 [GO] 2021―Jan―16 Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication Konstantinos Farsalinos, Pantelis G. Bagos, Theodoros Giannouchos, Raymond Niaura, Anastasia Barbouni, Konstantinos Poulas
64 [GO] 2020―Dec―01 Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response Rebecca Wilkinson, Lindsey Hines, Adam Holland, Sema Mandal, Emily Phipps
65 [GO] 2020―Nov―17 Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic Marcus Castillo, Brianna Conte, Sam Hinkes, Megan Mathew, C. J. Na, Ainhoa Norindr, et al. (+5)
66 [GO] 2020―Nov―04 The impact of the COVID-19 pandemic on harm reduction services in Spain Camila A. Picchio, Jorge Valencia, Jason Doran, Tracy Swan, Marta Pastor, Elisa Martró, et al. (+2)
67 [GO] 2020―Aug―24 Harm reduction in an emergency response to homelessness during South Africa’s COVID-19 lockdown Tessa S. Marcus, Jan Heese, Andrew Scheibe, Shaun Shelly, Sasha X. Lalla, Jannie F. Hugo
68 [GO] 2020―Jul―17 A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report Des Crowley, Ide Delargy
69 [GO] 2020―May―06 Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Adrian Dunlop, Buddhima Lokuge, Debbie Masters, Marcia Sequeira, Peter Saul, Grace Dunlop, et al. (+6)
 [1] 

69 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec